These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


592 related items for PubMed ID: 28509579

  • 1. Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness.
    Phillips L, Basnyat B, Chang Y, Swenson ER, Harris NS.
    High Alt Med Biol; 2017 Jun; 18(2):121-127. PubMed ID: 28509579
    [Abstract] [Full Text] [Related]

  • 2. Intraocular pressure is not associated with acute mountain sickness.
    Cushing T, Paterson R, Haukoos J, Harris NS.
    High Alt Med Biol; 2013 Dec; 14(4):342-5. PubMed ID: 24377341
    [Abstract] [Full Text] [Related]

  • 3. Incidence of Mild Cognitive Impairment with Ascending Altitude.
    Algaze I, Phillips L, Inglis P, Lathrop G, Gadbois J, Rizzolo K, Harris NS.
    High Alt Med Biol; 2020 Jun; 21(2):184-191. PubMed ID: 32282276
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
    van Patot MC, Leadbetter G, Keyes LE, Maakestad KM, Olson S, Hackett PH.
    High Alt Med Biol; 2008 Jun; 9(4):289-93. PubMed ID: 19115912
    [Abstract] [Full Text] [Related]

  • 5. Assessment of Acute Mountain Sickness: Comparing the Chinese AMS Score to the Lake Louise Score.
    Wu Y, Zhao W, Liu B, Zhang J, Zhong Z, Zhou S, Xie J, Gao Y, Li P, Chen J.
    High Alt Med Biol; 2024 Sep; 25(3):164-173. PubMed ID: 38602430
    [Abstract] [Full Text] [Related]

  • 6. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS, Jurkiewicz C, Winstead-Derlega C, Navlyt A, Burns P, Walker A, Phillips C, Reilly A, Burnier A, Romero J, Warner K, Hackett P.
    High Alt Med Biol; 2019 Sep; 20(3):271-278. PubMed ID: 31259608
    [Abstract] [Full Text] [Related]

  • 7. Association between decreased osteopontin and acute mountain sickness upon rapid ascent to 3500 m among young Chinese men.
    Tang XG, Wen J, Zhang XS, Jiang DC.
    J Travel Med; 2018 Jan 01; 25(1):. PubMed ID: 30165389
    [Abstract] [Full Text] [Related]

  • 8. Visual analogue self-assessment of acute mountain sickness in adolescents: experience from two Himalayan expeditions.
    Slingo ME, Lowe FS, Pieri AR, Imray CH, British Schools Exploring Society.
    High Alt Med Biol; 2012 Sep 01; 13(3):185-92. PubMed ID: 22994518
    [Abstract] [Full Text] [Related]

  • 9. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM.
    Arch Intern Med; 2005 Feb 14; 165(3):296-301. PubMed ID: 15710792
    [Abstract] [Full Text] [Related]

  • 10. Impact of Sleeping Altitude on Symptoms of Acute Mountain Sickness on Mt. Fuji.
    Horiuchi M, Uno T, Endo J, Handa Y, Hasegawa T.
    High Alt Med Biol; 2018 Jun 14; 19(2):193-200. PubMed ID: 29741971
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis and prediction of the occurrence of acute mountain sickness measuring oxygen saturation--independent of absolute altitude?
    Leichtfried V, Basic D, Burtscher M, Gothe RM, Siebert U, Schobersberger W.
    Sleep Breath; 2016 Mar 14; 20(1):435-42. PubMed ID: 26032284
    [Abstract] [Full Text] [Related]

  • 12. Does This Patient Have Acute Mountain Sickness?: The Rational Clinical Examination Systematic Review.
    Meier D, Collet TH, Locatelli I, Cornuz J, Kayser B, Simel DL, Sartori C.
    JAMA; 2017 Nov 14; 318(18):1810-1819. PubMed ID: 29136449
    [Abstract] [Full Text] [Related]

  • 13. Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro.
    Jackson SJ, Varley J, Sellers C, Josephs K, Codrington L, Duke G, Njelekela MA, Drummond G, Sutherland AI, Thompson AA, Baillie JK.
    High Alt Med Biol; 2010 Nov 14; 11(3):217-22. PubMed ID: 20919888
    [Abstract] [Full Text] [Related]

  • 14. No evidence of intracranial hypertension in trekkers with acute mountain sickness when assessed noninvasively with distortion product otoacoustic emissions.
    Olzowy B, Abendroth S, von Gleichenstein G, Mees K, Stelter K.
    High Alt Med Biol; 2014 Sep 14; 15(3):364-70. PubMed ID: 25163023
    [Abstract] [Full Text] [Related]

  • 15. Comparison of scoring systems for assessment of acute mountain sickness.
    Wagner DR, Teramoto M, Knott JR, Fry JP.
    High Alt Med Biol; 2012 Dec 14; 13(4):245-51. PubMed ID: 23270440
    [Abstract] [Full Text] [Related]

  • 16. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
    Berger MM, Sareban M, Schiefer LM, Swenson KE, Treff F, Schäfer L, Schmidt P, Schimke MM, Paar M, Niebauer J, Cogo A, Kriemler S, Schwery S, Pickerodt PA, Mayer B, Bärtsch P, Swenson ER.
    J Appl Physiol (1985); 2022 Jun 01; 132(6):1361-1369. PubMed ID: 35511718
    [Abstract] [Full Text] [Related]

  • 17. Field Ultrasound Evaluation of Central Volume Status and Acute Mountain Sickness.
    Pitman JT, Thapa GB, Harris NS.
    Wilderness Environ Med; 2015 Sep 01; 26(3):319-26. PubMed ID: 25864086
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the Lake Louise Score for Acute Mountain Sickness and Its 2018 Version in a Cohort of 484 Trekkers at High Altitude.
    Richalet JP, Julia C, Lhuissier FJ.
    High Alt Med Biol; 2021 Dec 01; 22(4):353-361. PubMed ID: 34515528
    [Abstract] [Full Text] [Related]

  • 19. Effects of acetazolamide on cognitive performance during high-altitude exposure.
    Wang J, Ke T, Zhang X, Chen Y, Liu M, Chen J, Luo W.
    Neurotoxicol Teratol; 2013 Dec 01; 35():28-33. PubMed ID: 23280141
    [Abstract] [Full Text] [Related]

  • 20. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.
    Kayser B, Hulsebosch R, Bosch F.
    High Alt Med Biol; 2008 Dec 01; 9(1):15-23. PubMed ID: 18331216
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.